1.Acute Inflammation & SIRS
-
Upload
adhitya-phemaw-rahadi -
Category
Documents
-
view
222 -
download
0
Transcript of 1.Acute Inflammation & SIRS
-
8/9/2019 1.Acute Inflammation & SIRS
1/45
ACUTE INFLAMMATION
&SYSTEMIC INFLAMMATORYRESPONSE SYNDROME
Jeppri
PriandanaNivedita Yurnita
-
8/9/2019 1.Acute Inflammation & SIRS
2/45
OVERVIEW OFINFLAMMATION
INFLAMMATION Protective response intended to eliminate
the initial cause of cell injury as well as thenecrotic cells and tissues resulting from theoriginal insult.to heal and reconstitute the damagedtissue.Main components : Vascular Reaction an Cellular Res!onse"#acti$ate % 'e iators t(at are eri$e )ro' !las'a!roteins an $arious cells*
-
8/9/2019 1.Acute Inflammation & SIRS
3/45
Car inal si+ns : heat ( calor ), redness(ru%or ), and swelling ( tu'or ) due tothe vascular changes and cell recruitment.Pain ( olor ) and loss of function ( )unctio
laesa ) consequences of mediatorela oration and leu!ocyte"mediateddamage.
Se$eral t !es o) cells an 'olecules
!la i'!ortant roles in in,a''ation- #lood leu!ocytes and plasma proteins,$ells of vascular walls$ells and (%$M) of the surrounding connectivetissue
OVERVIEW OFINFLAMMATION
-
8/9/2019 1.Acute Inflammation & SIRS
4/45
T(e co'!onents o) acute an c(ronic in,a''atorres!onses an t(eir !rinci!al )unctions
-
8/9/2019 1.Acute Inflammation & SIRS
5/45
Ste!s o) t(e In,a''atorRes!onse
(&)'ecognition of the injurious agent
( )'ecruitment of leu!ocytes( )'emoval of the agent(*)'egulation (control) of the response(+)'esolution (repair)
Can %e Acute or Chronic
OVERVIEW OFINFLAMMATION
-
8/9/2019 1.Acute Inflammation & SIRS
6/45
-
8/9/2019 1.Acute Inflammation & SIRS
7/45
Ma.or Co'!onents in AcuteIn,a''ation
&) 0lterations in vascular cali er 1 ( Vaso ilation* causing erythema and warmth
) %/travasation and deposition of plasma uid andproteins (edema) # Increased vascularpermeability)
) %migration of the leu!ocytes from themicrocirculation and their accumulation in the focusof injury ( Cellular recruitment and activation *-
-
8/9/2019 1.Acute Inflammation & SIRS
8/45
Vaso ilatation Transient arteriolar
vasoconstriction ollowed byvasodilation
2nduced y mediators (eg. 3istamines)
4armth and redness at thein ammatory site5pens microvascular eds2ncreased intravascularhydrostatic pressure causes anearly transudate (protein"poor6ltrate of plasma) into interstitium.
-
8/9/2019 1.Acute Inflammation & SIRS
9/45
-
8/9/2019 1.Acute Inflammation & SIRS
10/45
-
8/9/2019 1.Acute Inflammation & SIRS
11/45
3istamines, rady!inins,leu!otrienes cause an early, rief (&+9 min.), immediate transientresponse in the form of endothelialcell contraction that leads tointercellular gaps in postcapillaryvenules
$yto!ine mediators (8;
-
8/9/2019 1.Acute Inflammation & SIRS
12/45
Endothelial injury results in vascularlea!age y causing endothelial cellnecrosis and detachment. >evere injuriesmay cause immediate direct endothelialcell damage (necrosis, detachment)ma!ing them lea!y until they are repaired(immediate sustained response ), or may
cause delayed damage as in thermal or?7 injury.
0ccumulation of activated leu!ocytesalong the vessel wall may pile"up and
damage the endothelium throughactivation and release of to/ic o/ygenradicals and proteolytic en-ymes(leukocyte-dependent endothelial cell
injury ) ma!ing the vessel lea!y.
-
8/9/2019 1.Acute Inflammation & SIRS
13/45
$ertain mediators (7%@
-
8/9/2019 1.Acute Inflammation & SIRS
14/45
Cellular Recruit'ent an Acti$ation
eu!ocytes leave the vasculatureroutinely through the followingsequence of events:
Margination and rolling 0dhesion and transmigration$hemota/is and activation
8hey are then free to participate in:Phagocytosis and degranulation
eu!ocyte"induced tissue injury
-
8/9/2019 1.Acute Inflammation & SIRS
15/45
-
8/9/2019 1.Acute Inflammation & SIRS
16/45
T ! C"M#$!% #R"C!&& "' $!( "C*T! MI+RATI",
-
8/9/2019 1.Acute Inflammation & SIRS
17/45
Chemota-is eu!ocytes follow chemical gradient
(chemotactic su stances) to site of injury#acterial products$omplement components ($+a)$yto!ines (chemo!ine family e-+ ., 2 "A)
8# * (00 meta olite)Produced in response to infections andtissue damage and during immunologicreactions
$eu.ocyte Activation >timuli for activation include micro es,
products of necrotic cells, and severalmediators
-
8/9/2019 1.Acute Inflammation & SIRS
18/45
$eu.ocyte Activation
-
8/9/2019 1.Acute Inflammation & SIRS
19/45
P1A2OCYTOSISConsists of three distinct butinterrelated steps :
/0Recognition and Attachment of
the particle to the ingestingleu!ocyte
10!ngul ment , with su sequentformation of a phagocytic vacuole
20 illing and degradation of theingested material
-
8/9/2019 1.Acute Inflammation & SIRS
20/45
'ecognition and 0ttachment"psonins
>peci6c surface receptors, which recogni-e eithercomponents of the micro es and dead cells, or host
proteins $oat micro es and target them for phagocytosis
(opsonization) examples : anti odies of the 2g@, rea!down
products of the complement protein $ , and collectins $orresponding receptors :
-
8/9/2019 1.Acute Inflammation & SIRS
21/45
Cilling and Degradation Production of micro icidal su stances ('5> E ysosomal %n-ymes) >timulates an oxidative burst :
o 5/ygen consumptiono @lycogenolysiso @lucose o/idationo Production of '5>
phagocyte oxidase o/idi-es ;0DP3 converts o/ygen to supero/ide ion >upero/ide converted hydrogen pero/ide(! " # "$ # $ " ! " ).
-
8/9/2019 1.Acute Inflammation & SIRS
22/45
ysosomes of neutrophils
(azurophilic granules ) containen-yme myelopero/idase (MP5) MP5 converts 3 5 to 35$l
(hypochlorous radical). Powerful o/idant andantimicro ial agent
0fter !xygen burst% 3 5 ro!en
down to water and ! " y catalase Dead microorganisms degraded
y lysosomal acid hydrolases
-
8/9/2019 1.Acute Inflammation & SIRS
23/45
P1A2OCYTOSIS OF A PARTICLE #e+- %acteria*
-
8/9/2019 1.Acute Inflammation & SIRS
24/45
eu!ocyte"induced
tissue injury Destructive en-ymes may entere/tracellular space in event of:9 regurgitation during feeding& premature degranulation
9
-
8/9/2019 1.Acute Inflammation & SIRS
25/45
-
8/9/2019 1.Acute Inflammation & SIRS
26/45
AA META3OLITES AND T1EIR ROLES ININFLAMMATION
-
8/9/2019 1.Acute Inflammation & SIRS
27/45
More >peci6c Mediators Cyto.ines
9 Protein cell products that act as a message to othercells, telling them how to ehave.
9 %/. 2 "&, 8;hort"acting solu le free"radical gas with manyfunctions
9 Produced y endothelial cells, macrophages, causes: 7ascular smooth muscle rela/ation and
vasodilation Cills micro es in activated macrophages $ounteracts platelet adhesion, aggregation, and
degranulation
-
8/9/2019 1.Acute Inflammation & SIRS
28/45
4inin & Clottin+ Casca e
-
8/9/2019 1.Acute Inflammation & SIRS
29/45
$omplement >ystem $omponents $&"$F present in inactive
form9 0ctivated via classic ($&) or alternative
($ ) pathways to generate M0$ ($+ 9 $F)that punch holes in micro e mem ranes
9 2n acute in ammation 7asodilation, vascular permea ility, mast cell
degranulation ($ a, $+a)
eu!ocyte chemota/in, increases integrinavidity ($+a)
0s an opsonin, increases phagocytosis ($ ,$ i)
-
8/9/2019 1.Acute Inflammation & SIRS
30/45
Co'!le'ent S ste'
-
8/9/2019 1.Acute Inflammation & SIRS
31/45
-
8/9/2019 1.Acute Inflammation & SIRS
32/45
-
8/9/2019 1.Acute Inflammation & SIRS
33/45
-
8/9/2019 1.Acute Inflammation & SIRS
34/45
De6nition
2nfection9 Presence of microorganisms in a normally
sterile site.
#acteremia9 $ultivata le acteria in the lood stream.
>epsis9 8he systemic response to infection.
2f associated with proven orclinically suspected infection, >2'> iscalled HsepsisI.
American College of Chest Physicians/Society of Critical Care Medicine ConsensusConference Committee. Crit Care Med. 1992;20 !"#$!%#.
-
8/9/2019 1.Acute Inflammation & SIRS
35/45
>2'>(>ystemic 2n ammatory 'esponse
>yndrome) 8he systemic response to a wide range of stresses.
9 8emperature J AK$ (& .*K) or L =K$ (F=.AK
-
8/9/2019 1.Acute Inflammation & SIRS
36/45
>evere >epsis
>epsis with organ hypoperfusionone of the followings :
9 >#P L F mm3g9 0cute mental status change9 Pa5 ( L = mm3g on '0 (Pa5 (
-
8/9/2019 1.Acute Inflammation & SIRS
37/45
-
8/9/2019 1.Acute Inflammation & SIRS
38/45
'elationship etween >2'>and >epsis
&one 'C et al( Chest1992;101 1"#$)).
-
8/9/2019 1.Acute Inflammation & SIRS
39/45
8he >epsis $ontinuum
0 clinical response arisingfrom a nonspeci6c insult,with of the following:
8 J A o$ or L = o$3' JF eats min'' J min4#$ J& , mm orL*, mm or J& N
ands
SIRS = systemic inflammatoryresponse syndrome
S*'S +ith a ,resumed or confirmed
infectious ,rocess
Chest 1992;101 1"##.
SepsisSIRSSevereSepsis
SepticShock
Se,sis +ithorgan failure
'efractoryhy,otension
-
8/9/2019 1.Acute Inflammation & SIRS
40/45
Mortalit rate in SIRS
'angel$-rausto( et al. AMA 2% 11%$12 ( 199).
-
8/9/2019 1.Acute Inflammation & SIRS
41/45
;ormal >ystemic 'esponseto 2nfection and 2njury (&)
eu!ocytosis Mo ili-es neutrophils into thecirculation
8achycardia 2ncreases cardiac output, lood owto injuried tissue
-
8/9/2019 1.Acute Inflammation & SIRS
42/45
;ormal >ystemic 'esponseto 2nfection and 2njury ( )
0cute"Phase 'esponses9 0nti"infective
2ncreases synthesis of complement factors,micro e pattern"recognition molecules(mannose"
inding lectin, #P, $'P, $D&*, 5thers) >equesters iron (lactoferrin) and -inc
(metallothionein)
Mandell et al. Princi,als and Practice of *nfectious iseases"th ed;90" 90"$92".
-
8/9/2019 1.Acute Inflammation & SIRS
43/45
;ormal >ystemic 'esponseto 2nfection and 2njury ( )
0nti"in ammatory9 'eleases anti"in ammatory neuroendocrine
hormones (cortisol, 0$83, epinephrine, "M>3) 2ncreases synthesis of proteins that help
prevent in ammation within the systemiccompartment $yto!ine antagonists (2 "&'a, s8;
-
8/9/2019 1.Acute Inflammation & SIRS
44/45
Nor'al S ste'icRes!onse to In)ectionan In.ur #5* Procoagulant
9 4alls oS infection, prevents systemic spread 2ncreases synthesis or release of 6 rinogen, P02"&, $*
Decreases synthesis of protein $, anti"throm in 222 Meta olic
9 Preserves euglycemia, mo ili-es fatty acids, aminoacids
%pinephrine, cortisol, glucagon, cyto!ines 8hermoregulatory
9 2nhi its micro ial growth
-
8/9/2019 1.Acute Inflammation & SIRS
45/45
Ris/ )actors o) se!sis
aggressive oncological chemotherapy and radiation therapy use of corticosteroid and immunosuppressive therapies for
organ transplants and in ammatory diseases longer lives of patients predisposed to sepsis, the elderly, diabetics,
cancer patients, patients with major organ failure, and with granulocyopenia.
;eonates are more li!ely to develop sepsis (e/ . group #>treptococcal infections ).
increased use of invasive devices such as surgical protheses, inhalationequipment, and intravenous and urinary catheters.
indiscriminate use of antimicro ial drugs that createconditions of overgrowth, coloni-ation, and su sequentinfection y aggressive, antimicro ial"resistant organisms .